Stocks and Investing
Stocks and Investing
Wed, May 20, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, May 19, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tony Butler Upgraded (ALLO) to Strong Buy and Held Target at $60 on, May 19th, 2020
Tony Butler of Roth Capital, Upgraded "Allogene Therapeutics, Inc." (ALLO) to Strong Buy and Held Target at $60 on, May 19th, 2020.
Tony has made no other calls on ALLO in the last 4 months.
There are 3 other peers that have a rating on ALLO. Out of the 3 peers that are also analyzing ALLO, 2 agree with Tony's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Asthika Goonewardene of "SunTrust Robinson Humphrey" Downgraded from Strong Buy to Hold and Increased Target to $32 on, Thursday, May 14th, 2020
- Shanshan Xu of "Berenberg" Initiated at Hold and Held Target at $27 on, Monday, February 24th, 2020
This is the rating of the analyst that currently disagrees with Tony
- Robert Burns of "HC Wainwright & Co." Reiterated at Strong Buy with Increased Target to $42 on, Thursday, May 14th, 2020